TURKEL CATHERINE C. 4
4 · Novus Therapeutics, Inc. · Filed Sep 7, 2018
Insider Transaction Report
Form 4
TURKEL CATHERINE C.
Chief Development Officer
Transactions
- Purchase
Common Stock
2018-09-05$3.97/sh+805$3,193→ 805 total(indirect: By Spouse)
Holdings
- 44,519
Common Stock